Sharekhan

Gufic BioSciences Ltd

Mon 17/03/2025,12:9:59 NSE: GUFICBIO

₹ 321.15 -5.75 (-1.76%)
BUY NOW Buy Gufic BioSciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Gufic BioSciences Ltd

Mon 17/03/2025,12:21:0

Gufic BioSciences Ltd

Mon 17/03/2025,12:9:59 | NSE : GUFICBIO

₹ 321.15-5.75 (-1.76%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 325.25

Previous Close

₹ 326.90

Volume

33401

Mkt Cap ( Rs. Cr)

₹3220.41

High

₹ 329.35

Low

₹ 320.55

52 Week High

₹ 504.25

52 Week Low

₹ 277.65

Book Value Per Share

₹ 57.26

Dividend Yield

0.03

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Gufic BioSciences Ltd

Your Vote -

Buy

83.33%

Hold

12.50%

Sell

4.17%

83.33%

24 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

58%

Sell Order Quantity

42%

Bid Price

Qty

320.30

32

320.00

1

320.00

6

320.00

16

320.00

21

Bid Total

15028

Bid Price

Qty

320.55

9

321.00

9

321.00

20

321.00

2

321.00

8

Bid Total

10664

Option Chain

Analyzes market sentiment, predicts Gufic BioSciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    21 Feb 2025, 2:32PM Written Transcript of Earnings Conference Call is attached herewith.

  • Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates

    21 Feb 2025, 2:31PM Gufic Biosciences Limited has informed the Exchange about Transcript

  • Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Feb 2025, 2:09PM Gufic Biosciences Limited has informed the Exchange about Schedule of meet

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    20 Feb 2025, 2:12PM Pursuant to the provisions of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    17 Feb 2025, 6:27PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Rec

  • Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Feb 2025, 6:23PM Gufic Biosciences Limited has informed the Exchange about Link of Recording

  • Gufic BioSciences Lt - Copy of Newspaper Publication

    15 Feb 2025, 2:07PM Gufic Biosciences Limited has informed the Exchange about Copy of Newspaper Publication

  • Gufic BioSciences Lt - Integrated Filing- Financial

    14 Feb 2025, 7:03PM Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024

  • Gufic BioSciences Lt - Integrated Filing (Financial)

    14 Feb 2025, 7:03PM Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024

  • Gufic BioSciences Lt - Investor Presentation

    14 Feb 2025, 6:39PM Gufic Biosciences Limited has informed the Exchange about Investor Presentation

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Investor Presentation

    14 Feb 2025, 6:30PM Investor Presentation is attached herewith.

  • Gufic BioSciences Lt - Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months En

    14 Feb 2025, 6:27PM Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2024 is attached herewith.

  • Gufic BioSciences Lt - Financial Result Updates

    14 Feb 2025, 6:27PM Gufic Biosciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.

  • Gufic BioSciences Lt Q3 net profit down 13.21% at Rs 19.32 cr

    14 Feb 2025, 6:20PM The company reported standalone net profit of Rs 19.32 crore for the quarter ended December 31, 2024 as compared to Rs 22.26 crore in the same period

  • Gufic BioSciences Lt - Outcome of Board Meeting

    14 Feb 2025, 6:19PM Gufic Biosciences Limited has informed the Exchange regarding Board meeting held on February 14, 2025.

  • Gufic BioSciences Lt - Board Meeting Outcome for Meeting Held On Friday, February 14, 2025

    14 Feb 2025, 6:19PM Outcome of the Board of Directors Meeting held on Friday, February 14, 2025 is attached herewith\r\n

  • Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Feb 2025, 11:29AM Gufic Biosciences Limited has informed the Exchange about Earnings Conference Call scheduled to be held on Monday, February 17, 2025

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 Feb 2025, 11:25AM Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requireme

  • Gufic BioSciences Lt - Board Meeting Intimation

    7 Feb 2025, 7:22PM GUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2025 to consider and approve the Quarterly Unaudited Fina

  • Gufic BioSciences Lt - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, Unaudited Financial Results (S

    7 Feb 2025, 7:12PM GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider a

  • Gufic BioSciences Lt - Shareholders meeting

    7 Feb 2025, 7:09PM Gufic Biosciences Limited has submitted the Exchange Voting Results of Postal Ballot along with the Scrutinizers report

  • Gufic BioSciences Lt - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    7 Feb 2025, 7:01PM Declaration of Voting Results of Postal Ballot along with the Scrutinizer's Report is attached herewith

  • Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Feb 2025, 4:49PM Gufic Biosciences Limited has informed the Exchange about Schedule of meet

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Feb 2025, 4:50PM Pursuant to the provisions of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20

  • Gufic BioSciences Lt - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    3 Feb 2025, 6:57PM GUFIC BIOSCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A

  • Gufic BioSciences Lt - General Updates

    3 Feb 2025, 5:49PM Gufic Biosciences Limited has informed the Exchange about appointment of Senior Management Personnel

  • Gufic BioSciences Lt - Intimation Of Appointment Of Senior Management Personnel

    3 Feb 2025, 5:44PM Intimation of appointment of Senior Management Personnel is attached herewith

  • Gufic BioSciences Lt - General Updates

    31 Jan 2025, 7:32PM Gufic Biosciences Limited has informed the Exchange about Intimation of Grant of Patent in Europe.

  • Gufic BioSciences Lt - Intimation Of Grant Of Patent In Europe

    31 Jan 2025, 7:31PM Intimation of grant of Patent in Europe is attached herewith.

  • Gufic BioSciences Lt has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    20 Jan 2025, 6:20PM As of December 2024, 72.51% is owned by Indian Promoters and 27.49% by Public. <p align=justify> Top five Promoters holding highest number of shares o

  • Gufic BioSciences Lt - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    14 Jan 2025, 7:25PM GUFIC BIOSCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A

  • Gufic BioSciences Lt - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    14 Jan 2025, 7:19PM GUFIC BIOSCIENCES LIMITED has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL

  • Gufic BioSciences Lt - General Updates

    14 Jan 2025, 6:58PM Gufic Biosciences Limited has informed the Exchange about Appointment of Senior Management Personnel

  • Gufic BioSciences Lt - Appointment Of Senior Management Personnel

    14 Jan 2025, 6:57PM Intimation for appointment of Senior Management Personnel - Dr. Kathiresan Rajasekar as President - International Business is attached herewith

  • Gufic BioSciences Lt - General Updates

    13 Jan 2025, 8:43PM Gufic Biosciences Limited has informed the Exchange about Intimation of subscription to equity shares in Veira Life FZE, Wholly Owned Subsidiary in Du

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    13 Jan 2025, 8:42PM Intimation of subscription to equity shares in Veira Life FZE, Wholly Owned Subsidiary in Dubai, UAE is attached herewith

  • Gufic BioSciences Lt - Copy of Newspaper Publication

    8 Jan 2025, 4:41PM Gufic Biosciences Limited has informed the Exchange about Copy of Newspaper Publication of Postal Ballot Notice and E-voting details is attached herew

  • Gufic BioSciences Lt - Notice Of Shareholders Meetings-XBRL

    8 Jan 2025, 4:35PM Gufic Biosciences Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot

  • Gufic BioSciences Lt - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2025, 5:43PM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2024 is attached herew

  • Gufic BioSciences Lt - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jan 2025, 5:42PM Gufic Biosciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Gufic BioSciences Lt - Shareholders meeting

    7 Jan 2025, 5:25PM Gufic Biosciences Limited has informed the Exchange regarding Notice of Postal Ballot

  • Gufic BioSciences Lt - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    7 Jan 2025, 5:22PM Intimation of Postal Ballot Notice is attached herewith.

  • Gufic BioSciences Lt - General Updates

    31 Dec 2024, 7:46PM Gufic Biosciences Limited has informed the Exchange about Change in name of Registrar and Share Transfer Agent ( RTA ) of the Company

  • Gufic BioSciences Lt - Change In Name Of Registrar And Share Transfer Agent ('RTA') Of The Company \r\n\r\n

    31 Dec 2024, 7:43PM Intimation for change in name of Registrar and Share Transfer Agent (\RTA\) is attached herewith.

  • Gufic BioSciences Lt - Trading Window-XBRL

    28 Dec 2024, 12:14PM Gufic Biosciences Limited has informed the Exchange about Closure of Trading Window

  • Gufic BioSciences Lt - Trading Window

    28 Dec 2024, 12:11PM Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations

  • Gufic BioSciences Lt - Updates

    27 Dec 2024, 9:30PM Gufic Biosciences Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange '.

  • Gufic BioSciences Lt - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    27 Dec 2024, 9:17PM GUFIC BIOSCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A

  • Gufic BioSciences Lt - Outcome of Board Meeting

    27 Dec 2024, 9:11PM Gufic Biosciences Limited has informed the Exchange regarding Board meeting held on December 27, 2024.

  • Gufic BioSciences Lt - Board Meeting Outcome for Meeting Held On Friday, December 27, 2024

    27 Dec 2024, 9:06PM Outcome of the Board of Directors Meeting held on Friday, December 27, 2024 is attached herewith

  • Gufic receives NMPA China nod for Prilocaine API

    19 Jun 2023 , 11:58AM Gufic Biosciences gets NMPA approval for Prilocaine API

  • Gufic BioSciences

    7 Jun 2022 , 10:08AM Gufic Biosciences: Has launched a new drug delivery system - Dual Chamber Bags at affordable price first time in the India markets. The product launch is basis the collaboration with its European partner. The dual chamber bags come with a peelable aluminium foil allowing the storage of unstable drugs which needs reconstitution just before the administration to the patient. With the launch of this product Gufic aims to capture a major share of Rs 3000 cr lyophilized antibacterial market in India and hence is Positive, though we do not have a coverage on the stock.

  • Gufic Bio gets two patent certificates; stk gains

    6 Jun 2017 , 12:58PM Gufic Biosciences rises over 7% to Rs73.75, after receiving two patent certificates from Intellectual Property India
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Gufic BioSciences Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 849.595 659.2153 330.3601 225.1873 241.9697
Liabilities 849.595 659.2153 330.3601 225.1873 241.9697
Equity 10.0278 9.6945 9.6945 9.6945 9.6945
Gross Profit 145.8714 134.6513 145.7147 83.9195 52.1155
Net Profit 86.1356 79.7048 95.8401 44.2316 22.6879
Cash From Operating Activities -7.4571 -26.5872 104.4442 89.0648 47.1018
NPM(%) 10.67 11.54 12.3 9.06 5.98
Revenue 806.6657 690.6208 779.1556 487.6987 378.8374
Expenses 660.7943 555.9695 633.4409 403.7792 326.7219
ROE(%) 15 13.88 16.69 7.7 3.95

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
18 Sep 2024 0.1 10 0.03 321.05
24 Aug 2022 0.1 10 0.03 243.9
09 Sep 2021 0.1 10 0.03 190.7
03 Nov 2020 0.05 5 0.03 102.1
20 Sep 2019 0.05 5 0.03 59.7
0.05 5 0.03 145.55
28 Aug 2017 0.05 5 0.03 66.25
19 Sep 2016 0.05 5 0.03 41.05
22 Sep 2015 0.05 5 0.03 14.05
18 Sep 2014 0.05 5 0.03 20.9
02 Sep 2013 0.05 5 0.03 5.55
16 Aug 2012 0.05 5 0.03 7.75
16 Sep 2011 0.05 5 0.03 6.05
20 Sep 2010 0.05 5 0.03 6.35
17 Sep 2009 0.05 5 0.03 6.35
11 Dec 2008 0.05 5 0.03 4.45
19 Mar 2008 0.05 5 0.03 9.45
20 Sep 2006 0.16 16 0.03 11.7
22 Sep 2005 0.22 22 0.03 29.75

Peers

Other companies within the same industry or sector that are comparable to Gufic BioSciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 805.35 -0.35 11.37 186.74 1321.50 1.43
Lotus Eye Hospital and Institute Ltd 56.59 -0.82 235.79 680.45 14.01 0.88
Vaishali Pharma Ltd 12.02 -0.83 601.00 350.73 2.31 0.00
Astec Lifesciences Ltd 667.05 2.01 0.00 641.61 -239.30 0.00

Company Info

Central Finance Ltd. is a Bombay based company engaged in leasing, bill discounting, loan syndication, merchant banking/advisory services, investments, debt operations, portfolio management scheme, underwriting etc. Central Finance Securities Ltd. is the subsidiary of the company. The company has 100% stake in the subsidiary. 2000 - The Company name of changed to Gufic Biosciences Ltd. 2003 -Forays into vegetables market under the brand 'Gufic seeds'. 2004 -Gufic Biosciences eyes JV in biotech biz 2005 -Gufic Biosciences - Launch of new products 2007 -Gufic Biosciences Ltd has appointed Dr. M C Dhapalapur as Director of the Company on the Board of Directors of the Company with effect from August 01, 2007. 2008 - The Company has set up manufacturing facility for manufacture of Oncology Products. 2012 - The Board of Directors of the Company, inter alia, has recommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2013 -Gufic Biosciences Ltd has irecommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2014 - Ms. Hemal Deasi, Non- Independent Director has been appointed as an Additional Director. -Gufic Biosciences Ltd has recommended a dividend of Re. 0.05 per share on equity share of Rs. 1/- each.

Central Finance Ltd. is a Bombay based company engaged in leasing, bill discounting, loan syndication, merchant banking/advisory services, investments, debt operations, portfolio management scheme, underwriting etc. Central Finance Securities Ltd. is the subsidiary of the company. The company has 100% stake in the subsidiary. 2000 - The Company name of changed to Gufic Biosciences Ltd. 2003 -Forays into vegetables market under the brand 'Gufic seeds'. 2004 -Gufic Biosciences eyes JV in biotech biz 2005 -Gufic Biosciences - Launch of new products 2007 -Gufic Biosciences Ltd has appointed Dr. M C Dhapalapur as Director of the Company on the Board of Directors of the Company with effect from August 01, 2007. 2008 - The Company has set up manufacturing facility for manufacture of Oncology Products. 2012 - The Board of Directors of the Company, inter alia, has recommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2013 -Gufic Biosciences Ltd has irecommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2014 - Ms. Hemal Deasi, Non- Independent Director has been appointed as an Additional Director. -Gufic Biosciences Ltd has recommended a dividend of Re. 0.05 per share on equity share of Rs. 1/- each.

Read More

Parent Organisation

Gufic BioSciences Ltd.

Founded

23/07/1984

Managing Director

Mr.Jayesh P Choksi

NSE Symbol

GUFICBIOEQ

FAQ

The current price of Gufic BioSciences Ltd is ₹ 321.15.

The 52-week high for Gufic BioSciences Ltd is ₹ 329.35 and the 52-week low is ₹ 320.55.

The market capitalization of Gufic BioSciences Ltd is currently ₹ 3220.41. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Gufic BioSciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Gufic BioSciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Gufic BioSciences Ltd shares.

The CEO of Gufic BioSciences Ltd is Mr.Jayesh P Choksi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT